Jonathan Ginsberg 4/29/25 Jonathan Ginsberg 4/29/25 Vesicor Therapeutics, Inc. and Black Hawk Acquisition Corporation Enter into a Business Combination Agreement to Create a Biotechnology Company Advancing p53-based Cancer Therapeutics Delivered Read More Jonathan Ginsberg 3/24/24 Jonathan Ginsberg 3/24/24 Black Hawk Acquisition Corporation Announces Closing of $69,000,000 Initial Public Offering Read More Jonathan Ginsberg 3/20/24 Jonathan Ginsberg 3/20/24 Black Hawk Acquisition Corporation Announces Pricing of $69,000,000 Upsized Initial Public Offering Read More
Jonathan Ginsberg 4/29/25 Jonathan Ginsberg 4/29/25 Vesicor Therapeutics, Inc. and Black Hawk Acquisition Corporation Enter into a Business Combination Agreement to Create a Biotechnology Company Advancing p53-based Cancer Therapeutics Delivered Read More
Jonathan Ginsberg 3/24/24 Jonathan Ginsberg 3/24/24 Black Hawk Acquisition Corporation Announces Closing of $69,000,000 Initial Public Offering Read More
Jonathan Ginsberg 3/20/24 Jonathan Ginsberg 3/20/24 Black Hawk Acquisition Corporation Announces Pricing of $69,000,000 Upsized Initial Public Offering Read More
